BIO-key International, Inc. (BKYI)
NASDAQ: BKYI · Real-Time Price · USD
1.300
+0.060 (4.84%)
Nov 4, 2024, 4:00 PM EST - Market closed
BIO-key International Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Revenue | 6.96 | 7.75 | 7.02 | 5.11 | 2.84 | 2.27 | Upgrade
|
| Revenue Growth (YoY) | -3.86% | 10.46% | 37.26% | 80.29% | 25.10% | -43.94% | Upgrade
|
| Cost of Revenue | 3.96 | 6.32 | 2.44 | 1.67 | 0.79 | 2.46 | Upgrade
|
| Gross Profit | 3.01 | 1.43 | 4.58 | 3.44 | 2.04 | -0.19 | Upgrade
|
| Selling, General & Admin | 7.51 | 7.86 | 9.36 | 6.03 | 5.85 | 5.04 | Upgrade
|
| Research & Development | 2.35 | 2.39 | 3.25 | 2.36 | 1.4 | 1.33 | Upgrade
|
| Operating Expenses | 9.86 | 10.26 | 12.62 | 8.38 | 7.25 | 6.37 | Upgrade
|
| Operating Income | -6.85 | -8.83 | -8.04 | -4.94 | -5.2 | -6.56 | Upgrade
|
| Interest Expense | -0.11 | -0.22 | -1.16 | -0.02 | -4.34 | -1.07 | Upgrade
|
| Interest & Investment Income | 0.01 | 0.01 | 0 | 0 | 0.03 | 0 | Upgrade
|
| Currency Exchange Gain (Loss) | -0.02 | -0.04 | - | -0.05 | - | - | Upgrade
|
| Other Non Operating Income (Expenses) | -0 | - | - | - | - | - | Upgrade
|
| EBT Excluding Unusual Items | -6.98 | -9.07 | -9.19 | -5.01 | -9.52 | -7.63 | Upgrade
|
| Impairment of Goodwill | - | - | -2.39 | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | -0.45 | -0.06 | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | 0.02 | 0.02 | - | - | - | - | Upgrade
|
| Asset Writedown | - | - | - | - | - | -6.96 | Upgrade
|
| Other Unusual Items | 0.3 | 0.4 | 0.1 | - | -0.16 | - | Upgrade
|
| Pretax Income | -6.66 | -8.66 | -11.93 | -5.07 | -9.67 | -14.59 | Upgrade
|
| Income Tax Expense | -0.28 | -0.13 | -0.02 | - | - | - | Upgrade
|
| Net Income | -6.39 | -8.52 | -11.91 | -5.07 | -9.67 | -14.59 | Upgrade
|
| Preferred Dividends & Other Adjustments | - | - | - | - | 0.11 | - | Upgrade
|
| Net Income to Common | -6.39 | -8.52 | -11.91 | -5.07 | -9.79 | -14.59 | Upgrade
|
| Shares Outstanding (Basic) | 1 | 1 | 0 | 0 | 0 | 0 | Upgrade
|
| Shares Outstanding (Diluted) | 1 | 1 | 0 | 0 | 0 | 0 | Upgrade
|
| Shares Change (YoY) | 123.34% | 28.26% | 0.91% | 65.75% | 164.39% | 22.53% | Upgrade
|
| EPS (Basic) | -5.80 | -15.21 | -27.26 | -11.70 | -37.47 | -147.69 | Upgrade
|
| EPS (Diluted) | -5.80 | -15.21 | -27.26 | -11.70 | -37.47 | -147.69 | Upgrade
|
| Free Cash Flow | -2.82 | -3.79 | -6.31 | -9.02 | -4.99 | -1.88 | Upgrade
|
| Free Cash Flow Per Share | -2.56 | -6.77 | -14.45 | -20.84 | -19.09 | -19.02 | Upgrade
|
| Gross Margin | 43.15% | 18.46% | 65.25% | 67.29% | 71.98% | -8.54% | Upgrade
|
| Operating Margin | -98.39% | -113.82% | -114.47% | -96.62% | -183.42% | -289.40% | Upgrade
|
| Profit Margin | -91.72% | -109.89% | -169.65% | -99.05% | -344.99% | -643.37% | Upgrade
|
| Free Cash Flow Margin | -40.56% | -48.93% | -89.90% | -176.37% | -175.75% | -82.87% | Upgrade
|
| EBITDA | -6.41 | -8.4 | -7.69 | -4.67 | -5.04 | -6.45 | Upgrade
|
| EBITDA Margin | -92.03% | -108.27% | -109.60% | -91.33% | -177.64% | -284.54% | Upgrade
|
| D&A For EBITDA | 0.44 | 0.43 | 0.34 | 0.27 | 0.16 | 0.11 | Upgrade
|
| EBIT | -6.85 | -8.83 | -8.04 | -4.94 | -5.2 | -6.56 | Upgrade
|
| EBIT Margin | -98.39% | -113.82% | -114.47% | -96.62% | -183.42% | -289.40% | Upgrade
|
| Revenue as Reported | 6.96 | 7.75 | 7.02 | - | 2.84 | 2.27 | Upgrade
|
| Advertising Expenses | - | 0.34 | 0.84 | 0.53 | 0.49 | 0.32 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.